107 related articles for article (PubMed ID: 8892994)
1. How does morphine work?
Iversen LL
Nature; 1996 Oct; 383(6603):759-60. PubMed ID: 8892994
[No Abstract] [Full Text] [Related]
2. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
[TBL] [Abstract][Full Text] [Related]
3. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
[TBL] [Abstract][Full Text] [Related]
4. The molecular perspective: morphine.
Goodsell DS
Oncologist; 2004; 9(6):717-8. PubMed ID: 15561815
[No Abstract] [Full Text] [Related]
5. Rewarding effects of opiates are absent in mice lacking the receptor for substance P.
Murtra P; Sheasby AM; Hunt SP; De Felipe C
Nature; 2000 May; 405(6783):180-3. PubMed ID: 10821273
[TBL] [Abstract][Full Text] [Related]
6. Peptide and nonpeptide ligands for opioid receptors.
Misicka A
Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
[TBL] [Abstract][Full Text] [Related]
7. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
8. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
10. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
Roychoudhury M; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
12. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of morphine-6beta-glucuronide.
Lötsch J
Anesthesiology; 2009 Jun; 110(6):1209-10. PubMed ID: 19417609
[No Abstract] [Full Text] [Related]
14. The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain.
He L; Whistler JL
Pharmacology; 2007; 79(4):193-202. PubMed ID: 17356311
[TBL] [Abstract][Full Text] [Related]
15. Altered gating of opiate receptor-modulated K+ channels on amygdala neurons of morphine-dependent rats.
Chen X; Marrero HG; Murphy R; Lin YJ; Freedman JE
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14692-6. PubMed ID: 11121070
[TBL] [Abstract][Full Text] [Related]
16. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.
Befort K; Filliol D; Ghate A; Darcq E; Matifas A; Muller J; Lardenois A; Thibault C; Dembele D; Le Merrer J; Becker JA; Poch O; Kieffer BL
Eur J Neurosci; 2008 Jun; 27(11):2973-84. PubMed ID: 18588537
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of morphine- and cocaine-induced nNOS immunoreactivity in the dentate gyrus of hippocampus of mice lacking mu-opioid receptors.
Yoo JH; Cho JH; Lee SY; Lee S; Loh HH; Ho IK; Jang CG
Neurosci Lett; 2006 Mar; 395(2):98-102. PubMed ID: 16300892
[TBL] [Abstract][Full Text] [Related]
18. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
19. Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency.
Aitta-aho T; Möykkynen TP; Panhelainen AE; Vekovischeva OY; Bäckström P; Korpi ER
PLoS One; 2012; 7(5):e38325. PubMed ID: 22675452
[TBL] [Abstract][Full Text] [Related]
20. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
